First Trust Advisors
RNAM

First Trust Advisors’s Avidity Biosciences RNAM Stock Holding History

First Trust Advisors’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,890
Closed -$2.88M – 2708
2025
Q4 		$2.88M Buy
+39,890
New +$2.58M ﹤0.01% 1712
2025
Q1 		– Sell
-86,395
Closed -$2.51M – 2608
2024
Q4 		$2.51M Buy
86,395
+45,254
+110% +$1.89M ﹤0.01% 1708
2024
Q3 		$1.89M Buy
+41,141
New +$1.79M ﹤0.01% 1794

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

First Trust Advisors's RNAM Position: Q1 2026 in Review

First Trust Advisors sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 39,890 shares — an estimated $2.88M sold.

First Trust Advisors first reported a position in RNAM in Q3 2024 and held it in 3 quarters. The position peaked at $2.88M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • First Trust Advisors reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • First Trust Advisors sold 39,890 Avidity Biosciences shares in Q1 2026, an estimated $2.88M.
  • First Trust Advisors first reported a position in Avidity Biosciences in Q3 2024 and held it in 3 quarters.
  • First Trust Advisors's Avidity Biosciences position peaked at $2.88M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.